NEUMORA THERAPEUTICS INC (NMRA) Institutional Ownership Changes & 13F Activity

NEUMORA THERAPEUTICS INC (NMRA) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-56,9041,388,998$2,708,546
Q4 2025Renaissance Technologies LLCBuy281,9261,445,902$2,588,165
Q3 2025Renaissance Technologies LLCSell-270,5511,163,976$2,118,436
Q2 2025Renaissance Technologies LLCBuy174,9971,434,527$1,051,939
Q1 2025Renaissance Technologies LLCBuy1,120,6301,259,530$1,259,530
Q1 2024Renaissance Technologies LLCBuy125,300138,900$1,910
Q4 2023Renaissance Technologies LLCBuy13,60013,600$232

Frequently asked questions about NMRA activity

  • Which institutional owners are buying NMRA?

    Institutional owners buying NMRA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in NMRA activity?

    "Buy" means an investor increased their reported position in NMRA compared to the prior reporting period. This reflects growing exposure to NEUMORA THERAPEUTICS INC (NMRA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in NMRA increasing?

    Institutional interest in NMRA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related NMRA insights